Herbalgy, Pain Management Expert, Harnesses the Wisdom of Traditional Chinese Medicine to Safeguard Hong Kong’s Health, Proudly Appoints Moses Chan as Brand Ambassador
Download high-resolution images: https://cutt.ly/IrGBefFJ HONG KONG, Aug. 18, 2025 /PRNewswire/ -- As Hong Kong's pain management expert, Herbalgy has been serving the community since its founding in 1999. For over 25 years, the brand has been dedicated to promoting healthy living and pain management, with a steadfast commitment to product innovation. By...
New support group to provide social and community support for neurofibromatosis patients
Co-founded by individuals living with this rare genetic condition, the Neurofibromatosis Society Singapore seeks to close gaps in mental and emotional care SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- A new patient-led support group, the Neurofibromatosis Society (NFS) Singapore, has been recently registered with the Registry of Societies to provide emotional, psychosocial, and financial support for people affected by neurofibromatosis (NF) – a...
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal...
- Combination of a low dose of ASC47 with ASC31, a novel peptide agonist targeting both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), resulted in a 44.8% reduction in body weight after 14 days of treatment in a diet-induced obese (DIO) mouse model. - Combination of a low dose of ASC47 with ASC31 demonstrated statistically significantly greater efficacy...
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation
Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 2025, underscoring its ability to deliver profitable growth at scale through strategic globalization, differentiated technology, and relentless...
VARON’s Lung Health Awareness Initiative Urges Proactive Steps for Allergy and Flu this Fall Season
NEW YORK, Aug. 15, 2025 /PRNewswire/ -- With allergy and flu season approaching, VARON is calling on individuals to take preventive measures to protect their lungs. Through its "Every Breath Counts" initiative, the oxygen concentrator manufacturer is partnering with respiratory health experts to share practical lung care strategies and introduce tools — from at home...
BestQool Announces Summer Promotion and Fall Refresh with New Logo and BQ60Pro Preview
Summer Appreciation Sales Offers 12% Off All Products NEW YORK, Aug. 15, 2025 /PRNewswire/ -- BestQool , a pioneer manufacturer of home-use red light therapy devices, is excited to unveil its latest breakthrough product – the BQ60Pro. Based on years of experience and customer feedback, this small yet powerful home-use device now provides six wavelengths for maximum therapeutic protocols,...
Tie “James” Li, Chairman of NMHI, To Speak at XRP Seoul 2025 Global Conference
ONTARIO, Calif., Aug. 15, 2025 /PRNewswire/ -- Tie "James" Li, Chairman and CEO of Nature's Miracle Holding Inc. (OTCQB:NMHI) will attend the XRP Seoul 2025 Global Conference as a keynote speaker on September 21, 2025. XRP SEOUL 2025 hosted by XRPL Korea is a global conference bringing together XRP holders, developers, and ecosystem...
Novel Gene Therapy for ALS cleared for global trials in China and the U.S.
BEIJING, Aug. 15, 2025 /PRNewswire/ -- SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SNUG01, a groundbreaking gene therapy product for amyotrophic lateral sclerosis (ALS). This milestone follows a prior clearance of...
So-Young Reports Unaudited Second Quarter 2025 Financial Results
BEIJING, Aug. 15, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenues were RMB378.7 million (US$52.9 million), compared with...
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Shanghai, Aug. 15, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that etrasimod (VELSIPITY®) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults (the "Updated Guidelines"). In patients with moderately to severely active ulcerative colitis (UC),...
